Advanced Cell Technology, Inc. (OTC:ACTC) Penny Stock Crushed The Investors Expectations On Jan 30th, 2012

Company Background Advanced Cell Technology, Inc. (OTC:ACTC):

Advanced Cell Technology is a Biotechnology Company and focuses on the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. The company’s embryonic stem cell research programs contain cellular reprogramming, reduced complexity program and stem cell differentiation research programs. The company headquartered situated in Marlborough, Massachusetts.

Financial Analysis:

Advanced Cell Technology, Inc. (OTC:ACTC) generated the total revenue of $0.13 million for the quarter ended September 30th, 2011 as compared to revenue of $0.21 million for the same period last year. The company reported the net loss of $52.22 million or earnings loss of $0.03 per share for the respective quarter as compared to net income of $1.94 million or earnings of $0.01 per share last year.

The company’s total assets accumulate up to $16.29 million out of which fixed assets have the highest proportion. The company maintains a short term liquidity position as per its current ratio of 0.29 times.